Subcutaneous immunoglobulin therapy for adult patients with primary immunodeficiency disease: Qatar experience

Introduction: Subcutaneous immunoglobulin (SCIG) and intravenous immunoglobulin (IVIG) are used for the treatment of primary immunodeficiency (PIDD). SCIG is as effective as IVIG in preventing infections.(1) However, SCIG has advantages over IVIG as it causes fewer systemic reactions and can be infu...

Descripción completa

Detalles Bibliográficos
Autores principales: Thalappil, Sherin, Khalil, Sally, Hassini, Slim, Al-Nesf, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: HBKU Press 2023
Materias:
Second Qatar Allergy Conference
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660831/
https://www.ncbi.nlm.nih.gov/pubmed/38025333
http://dx.doi.org/10.5339/qmj.2023.sqac.3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660831/
https://www.ncbi.nlm.nih.gov/pubmed/38025333
http://dx.doi.org/10.5339/qmj.2023.sqac.3

Ejemplares similares